US Patent Issued to UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, RIJKSUNIVERSITEIT GRONINGEN on March 3 for "Chemically-stabilized allosteric modulators of leucine-rich repeat kinase 2 (LRRK2)" (American, Dutch Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,520, issued on March 3, was assigned to UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC. (Athens, Ga.) and RIJKSUNIVERSITEIT GRONINGEN (Groningen, Netherlands).

"Chemically-stabilized allosteric modulators of leucine-rich repeat kinase 2 (LRRK2)" was invented by Eileen J. Kennedy (Athens, Ga.), Arjan Kortholt (Groningen, Netherlands) and Leah G. Helton (Chattanooga, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure describes synthetic polypeptides for the inhibition or modulation of the activity of leucine-rich repeat kinase 2 (LRRK2) along with methods of using the same in the treatment of medical conditions, for example neu...